The Enriched Environment as an Integrated Tool in the Ward Setting
Launched by UNIVERSITY OF PADOVA · Jan 27, 2024
Trial Information
Current as of March 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Enriched Environment as an Integrated Tool in the Ward Setting," is exploring how a special program, called an enriched environment (EE), can help people who have had a stroke. The study is taking place in the Neurology Clinic at the University of Padua and aims to see if this program can improve patients' psychological well-being, help them recover their physical abilities, increase their activity levels, and enhance their overall quality of life.
To participate in this trial, individuals must be between the ages of 65 and 74 and have experienced either an ischemic (caused by a blockage) or hemorrhagic (caused by bleeding) stroke at least 24 hours before joining. They also need to give their consent to participate and be medically stable. However, those who are unable to cooperate due to severe cognitive or physical challenges, such as significant difficulty sitting up or understanding speech, will not be eligible. Participants can expect to engage in activities designed to support their recovery in a supportive environment, which might lead to improvements in their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ischaemic or haemorrhagic stroke, in any territory, occurring at least 24 hours before enrollment;
- • Participant consent to participate in the study;
- • Mecial stabilisation.
- Exclusion Criteria:
- • Uncooperative participant, as assessed by theMontreal Cognitive Assessment scale \< 15
- • medically not stabtability and/or reduced level of consciousness and/or psychomotor agitation;
- • Lack of trunk control (score \<12 in item 3 of the Trunk Control Test: balance in sitting position) such that it is impossible to maintain a sitting position or a safe posture in a wheelchair;
- • Speech evaluation confirming comprehension aphasia hampering understanding of informed consent.
Trial Officials
Alessandra Del Felice, MD, PhD
Principal Investigator
University of Padova
About University Of Padova
The University of Padova, a prestigious research institution in Italy, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment conducive to the development of novel therapies and treatment modalities. Its commitment to ethical standards, patient safety, and scientific rigor ensures that all clinical trials are conducted with the highest level of integrity. Through these initiatives, the University of Padova aims to contribute significantly to the global medical community and improve health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Padova, , Italy
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0